Topics

Drinking Water Wastewater Treatment Smart Water Asset Management Water Utility Management

Resources

Global Thought Leaders Events Magazine WaterWorldTV White Papers Webcasts

User Tools

Subscribe Advertise About Us Contact Us Privacy Policy Terms & Conditions

Press Releases

https://www.facebook.com/waterworldmag

https://www.linkedin.com/showcase/waterworld-magazine/about/

https://twitter.com/WaterWorld

Recent Quotes

My Watchlist

Indicators

WaterWorld Market Index

Markets:

Overview

News

Currencies

International

Treasuries

Amicus Therapeutics, Inc. - Common Stock (NQ:FOLD)

14.37 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amicus Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Rice Hall James Buys QuidelOrtho Stock ↗

March 09, 2026

QuidelOrtho develops diagnostic technologies for healthcare providers worldwide, spanning labs, clinics, and retail settings.

Via The Motley Fool

Topics Regulatory Compliance

Rice Hall James Buys Stride Stock ↗

March 09, 2026

Stride delivers online and blended education solutions for K-12, career, and adult learners through proprietary technology platforms.

Via The Motley Fool

Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing ↗

March 03, 2026

PTC Therapeutics develops therapies for rare diseases, with a portfolio spanning commercial products and investigational candidates.

Via The Motley Fool

Topics Regulatory Compliance

Amicus Stock Surges To Near 2-Year Highs On BioMarin's $4.8B Buyout Deal ↗

December 19, 2025

Via Stocktwits

Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing ↗

March 02, 2026

This clinical-stage biotech develops therapies for rare muscle diseases using its proprietary FORCE platform and research-driven approach.

Via The Motley Fool

Topics Regulatory Compliance

Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing ↗

March 02, 2026

This clinical-stage biotech develops antibody therapeutics targeting cancer, with a pipeline focused on oncology and immunotherapy markets.

Via The Motley Fool

Topics Regulatory Compliance

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

February 20, 2026

From Amicus Therapeutics, Inc.

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether RAPT, CTGO, TBN, FOLD are Obtaining Fair Deals for their Shareholders

February 19, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Amicus Therapeutics Presents New Long-term Data for both Galafold® (migalastat) and POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at the 22nd Annual WORLDSymposium™ 2026

February 03, 2026

From Amicus Therapeutics, Inc.

Via GlobeNewswire

Halper Sadeh LLC Reminds Shareholders of JHG, FOLD, RAPT of the Firm’s Investigations

February 02, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

Should You Buy BioMarin Pharmaceutical Before Feb. 18? ↗

January 31, 2026

There's no need to hurry in buying this biotech stock.

Via The Motley Fool

Topics Earnings

FOLD Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Amicus Therapeutics, Inc. is Fair to Shareholders

January 23, 2026

From Halper Sadeh LLC

Via Business Wire

Halper Sadeh LLC Encourages PEN, FOLD, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their Rights

January 22, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC Encourages EKSO, FOLD, CWAN, JHG Shareholders to Contact the Firm to Discuss Their Rights

January 07, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

The Great Unlocking: 2026 Opens with a Historic Surge in Large-Cap M&A Activity

January 06, 2026

The first week of 2026 has signaled a tectonic shift in the global financial landscape, as a wave of multi-billion dollar acquisitions has effectively ended the deal-making drought of the previous two...

Via MarketMinute

Topics Artificial Intelligence Economy Energy

Halper Sadeh LLC Encourages EKSO, FOLD, CWAN, JHG Shareholders to Contact the Firm to Discuss Their Rights

January 06, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights.

From Halper Sadeh LLC

Via GlobeNewswire

BioMarin’s $4.8 Billion Amicus Acquisition: A Strategic Pivot to Rare Disease Dominance

January 02, 2026

In a move that has sent shockwaves through the biotechnology sector, BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced on December 19, 2025, that it has entered into a definitive agreement to...

Via MarketMinute

Topics Economy Intellectual Property

Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal

December 29, 2025

The biopharmaceutical sector witnessed a dramatic surge in volatility today, December 29, 2025, as the industry careened toward the end of its strongest year in two decades. In a day defined by extreme...

Via MarketMinute

Topics ETFs Intellectual Property

Amicus Therapeutics Investment Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amicus Therapeutics, Inc. - FOLD

December 26, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

The Liquidity Vacuum: Thin Holiday Trading Sparks Volatility as 2025 Draws to a Close

December 26, 2025

As the final week of 2025 unfolds, the hallowed halls of the New York Stock Exchange and the digital corridors of the Nasdaq have transformed into a "ghost town." With many institutional traders having...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Clearwater Analytics Holdings, Inc. (NYSE - CWAN), Katapult Holdings, Inc. (Nasdaq - KPLT), Janus Henderson Group plc (NYSE - JHG), Amicus Therapeutics, Inc. (Nasdaq

December 23, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Unusual volume stocks in Tuesday's session ↗

December 23, 2025

Let's explore the current happenings on the US markets on Tuesday. Below, you'll find the stocks exhibiting unusual volume in today's session.

Via Chartmill

Halper Sadeh LLC Encourages FOLD, VYNE, HTBK, FMNB Shareholders to Contact the Firm to Discuss Their Rights

December 20, 2025

Shareholders should contact the firm as there may be limited time to enforce your rights.

From Halper Sadeh LLC

Via GlobeNewswire

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

December 19, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Discover the most active stocks in Friday's session. ↗

December 19, 2025

Let's have a look at what is happening on the US markets on Friday. Below you can find the most active stocks in today's session.

Via Chartmill

Which stocks are moving on Friday? ↗

December 19, 2025

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Via Chartmill

Which stocks are gapping on Friday? ↗

December 19, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

FOLD Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Amicus Therapeutics, Inc. is Fair to Shareholders

December 19, 2025

From Halper Sadeh LLC

Via Business Wire

Discover the top movers in Friday's pre-market session. ↗

December 19, 2025

Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations

December 04, 2025

Via Investor Brand Network

Topics Government

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

https://www.facebook.com/waterworldmag

https://www.linkedin.com/showcase/waterworld-magazine/about/

https://twitter.com/WaterWorld

Subscribe
About Us
Contact Us
Do Not Sell or Share
Privacy Policy
Terms & Conditions